Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies

Hepatitis C virus (HCV) is a positive single-stranded RNA virus of enormous global health importance, with direct-acting antiviral therapies replacing an immunostimulatory interferon-based regimen. The dynamics of HCV positive and negative-strand viral RNAs (vRNAs) under antiviral perturbations have...

Full description

Bibliographic Details
Main Authors: Luna, Joseph M., Hoffmann, Hans.-Heinrich, Espiritu, Christine, Sheahan, Timothy P., Rice, Charles M., Ramanan, Vyas, Trehan, Kartik, Ong, Mei Lyn, Chandrasekar, Hamsika, Christine, Kathleen, van Oudenaarden, Alexander, Bhatia, Sangeeta N, Schwartz, Robert E.
Other Authors: Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Format: Article
Language:en_US
Published: Elsevier 2017
Online Access:http://hdl.handle.net/1721.1/110773
https://orcid.org/0000-0001-6214-4788
https://orcid.org/0000-0002-1293-2097
_version_ 1811092036316561408
author Luna, Joseph M.
Hoffmann, Hans.-Heinrich
Espiritu, Christine
Sheahan, Timothy P.
Rice, Charles M.
Ramanan, Vyas
Trehan, Kartik
Ong, Mei Lyn
Chandrasekar, Hamsika
Christine, Kathleen
van Oudenaarden, Alexander
Bhatia, Sangeeta N
Schwartz, Robert E.
author2 Massachusetts Institute of Technology. Institute for Medical Engineering & Science
author_facet Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Luna, Joseph M.
Hoffmann, Hans.-Heinrich
Espiritu, Christine
Sheahan, Timothy P.
Rice, Charles M.
Ramanan, Vyas
Trehan, Kartik
Ong, Mei Lyn
Chandrasekar, Hamsika
Christine, Kathleen
van Oudenaarden, Alexander
Bhatia, Sangeeta N
Schwartz, Robert E.
author_sort Luna, Joseph M.
collection MIT
description Hepatitis C virus (HCV) is a positive single-stranded RNA virus of enormous global health importance, with direct-acting antiviral therapies replacing an immunostimulatory interferon-based regimen. The dynamics of HCV positive and negative-strand viral RNAs (vRNAs) under antiviral perturbations have not been studied at the single-cell level, leaving a gap in our understanding of antiviral kinetics and host–virus interactions. Here, we demonstrate quantitative imaging of HCV genomes in multiple infection models, and multiplexing of positive and negative strand vRNAs and host antiviral RNAs. We capture the varying kinetics with which antiviral drugs with different mechanisms of action clear HCV infection, finding the NS5A inhibitor daclatasvir to induce a rapid decline in negative-strand viral RNAs. We also find that the induction of host antiviral genes upon interferon treatment is positively correlated with viral load in single cells. This study adds smFISH to the toolbox available for analyzing the treatment of RNA virus infections.
first_indexed 2024-09-23T15:11:54Z
format Article
id mit-1721.1/110773
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T15:11:54Z
publishDate 2017
publisher Elsevier
record_format dspace
spelling mit-1721.1/1107732022-09-29T13:19:40Z Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies Luna, Joseph M. Hoffmann, Hans.-Heinrich Espiritu, Christine Sheahan, Timothy P. Rice, Charles M. Ramanan, Vyas Trehan, Kartik Ong, Mei Lyn Chandrasekar, Hamsika Christine, Kathleen van Oudenaarden, Alexander Bhatia, Sangeeta N Schwartz, Robert E. Massachusetts Institute of Technology. Institute for Medical Engineering & Science Harvard-MIT Program in Health Sciences and Technology Massachusetts Institute of Technology. Computational and Systems Biology Program Massachusetts Institute of Technology. Department of Biology Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science Massachusetts Institute of Technology. Department of Physics Koch Institute for Integrative Cancer Research at MIT Ramanan, Vyas Trehan, Kartik Ong, Mei Lyn Chandrasekar, Hamsika Schwartz, Robert E Christine, Kathleen van Oudenaarden, Alexander Bhatia, Sangeeta N Hepatitis C virus (HCV) is a positive single-stranded RNA virus of enormous global health importance, with direct-acting antiviral therapies replacing an immunostimulatory interferon-based regimen. The dynamics of HCV positive and negative-strand viral RNAs (vRNAs) under antiviral perturbations have not been studied at the single-cell level, leaving a gap in our understanding of antiviral kinetics and host–virus interactions. Here, we demonstrate quantitative imaging of HCV genomes in multiple infection models, and multiplexing of positive and negative strand vRNAs and host antiviral RNAs. We capture the varying kinetics with which antiviral drugs with different mechanisms of action clear HCV infection, finding the NS5A inhibitor daclatasvir to induce a rapid decline in negative-strand viral RNAs. We also find that the induction of host antiviral genes upon interferon treatment is positively correlated with viral load in single cells. This study adds smFISH to the toolbox available for analyzing the treatment of RNA virus infections. National Cancer Institute (U.S.) (Grant 1 R01 CA057973) National Institute of Allergy and Infectious Diseases (U.S.) (Grant 1 R01 AI099284) National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) (NIH Roadmap for Medical Research Grant 1 R01 DK085713) National Cancer Institute (U.S.). Physical Sciences-Oncology Center (Grant U54 CA143874) National Institutes of Health (U.S.) (Pioneer Award 1DP1 OD003936) Starr Foundation Hertz Foundation National Science Foundation (U.S.). Graduate Research Fellowship Program 2017-07-19T14:03:18Z 2017-07-19T14:03:18Z 2016-04 2016-04 Article http://purl.org/eprint/type/JournalArticle 0042-6822 1096-0341 http://hdl.handle.net/1721.1/110773 Ramanan, Vyas et al. “Viral Genome Imaging of Hepatitis C Virus to Probe Heterogeneous Viral Infection and Responses to Antiviral Therapies.” Virology 494 (2016): 236–247. https://orcid.org/0000-0001-6214-4788 https://orcid.org/0000-0002-1293-2097 en_US http://dx.doi.org/10.1016/j.virol.2016.04.020 Virology Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/ application/pdf Elsevier PMC
spellingShingle Luna, Joseph M.
Hoffmann, Hans.-Heinrich
Espiritu, Christine
Sheahan, Timothy P.
Rice, Charles M.
Ramanan, Vyas
Trehan, Kartik
Ong, Mei Lyn
Chandrasekar, Hamsika
Christine, Kathleen
van Oudenaarden, Alexander
Bhatia, Sangeeta N
Schwartz, Robert E.
Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
title Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
title_full Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
title_fullStr Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
title_full_unstemmed Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
title_short Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
title_sort viral genome imaging of hepatitis c virus to probe heterogeneous viral infection and responses to antiviral therapies
url http://hdl.handle.net/1721.1/110773
https://orcid.org/0000-0001-6214-4788
https://orcid.org/0000-0002-1293-2097
work_keys_str_mv AT lunajosephm viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies
AT hoffmannhansheinrich viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies
AT espirituchristine viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies
AT sheahantimothyp viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies
AT ricecharlesm viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies
AT ramananvyas viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies
AT trehankartik viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies
AT ongmeilyn viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies
AT chandrasekarhamsika viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies
AT christinekathleen viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies
AT vanoudenaardenalexander viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies
AT bhatiasangeetan viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies
AT schwartzroberte viralgenomeimagingofhepatitiscvirustoprobeheterogeneousviralinfectionandresponsestoantiviraltherapies